Will London’s budding cannabis market turn the EU green with envy? February 18, 2021 One after the other, medical cannabis companies are listing on the London Stock Exchange (LSE), and investors are piling in cash, keen to be early investors in what they hope will become a major industry in the UK. It is an exciting time for the medicinal cannabis industry. In September, City regulator the Financial Conduct [...]
Cannabis rally goes up in smoke as shares plummet February 11, 2021 Cannabis stocks gave up its earlier highs on Thursday afternoon with leading US firms plummeting between 20 and 40 per cent. Cannabis stocks were among the most traded by German retail investors this morning, as a buying frenzy that has lit up the sector intensified. Tilray was the most traded stock on German trading platform [...]
Medical cannabis firm MGC Pharmaceuticals to float on LSE February 9, 2021 Medicinal cannabis firm MGC Pharmaceuticals has announced plans to float on the main market of the London Stock Exchange. MGC Pharma is a European-based bio-pharma company specialising in the production and development of phytocannabinoid-derived medicines. As part of the listing process, the company intends to raise gross proceeds of approximately £6.5m via institutional and other [...]
The new Greenback: Why investors are getting high on medicinal cannabis firms February 8, 2021 Avihu Tamir is CEO of Kanabo For years, advocates of medicinal cannabis products have predicted that the industry is set to revolutionise healthcare – and make investors a tidy profit. That time may finally be coming. Take our firm, Kanabo Group, which became the first medicinal cannabis company to get approval from the Financial Conduct [...]
David Beckham-backed cannabis firm on course to become LSE’s first CBD listing February 4, 2021 UK-based Cellular Goods is seeking a listing on the London Stock Exchange, which would make them the LSE’s first pure-play CBD business
High and dry: London medical cannabis company enters administration February 1, 2021 London-based pharmaceutical company Senzer has entered administration, after failing to get enough backing to float on the Alternative Investment Market. Professional services firm Begbies Traynor has been appointed administrator of Senzer, which entered administration in early January. Senzer developed and manufactured respiratory devices for medical cannabis use. Its core product was a breath-activated inhaler that [...]